白云山(600332.SH):获得冻干人用狂犬病疫苗(Vero细胞)药品注册证书
智通财经网·2025-12-25 10:02

Core Viewpoint - Baiyunshan (600332.SH) has received approval from the National Medical Products Administration for the registration of its freeze-dried human rabies vaccine (Vero cells), which is an effective method for preventing rabies [1] Company Summary - Baiyunshan's subsidiary, Guangzhou Baiyunshan Biological Products Co., Ltd., is the entity that received the drug registration certificate for the rabies vaccine [1] - The rabies vaccine is intended for the prevention of rabies, a serious infectious disease caused by the rabies virus, primarily transmitted through bites or scratches from infected animals such as dogs and cats [1] Industry Summary - The approval of the rabies vaccine aligns with the industry's focus on developing effective vaccines to control and prevent infectious diseases [1]